Report on mumps outbreak reflects vaccines' limited efficacy

04/9/2008 | WebMD · Reuters

Widespread use of two shots of the mumps vaccine manufactured by Merck & Co. did not prevent a U.S. outbreak of the disease in 2006. Of young adults who became ill, 84% had received the recommended two doses, CDC experts reported Wednesday. The findings suggest a better vaccine or changes in policy "may be needed to avert future outbreaks and achieve the elimination of mumps," the experts said.

View Full Article in:

WebMD · Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI